Target intelligence / Profile preview

Chloride channel protein 5 (ClC-5)

Target
ClC-5
Molecular classification
Ion channel, Transporter, Voltage-gated chloride channel family (ClC family)
01

Overview

Chloride channel protein 5 (ClC-5, encoded by the CLCN5 gene) is a voltage-dependent chloride/proton exchanger predominantly expressed in the kidneys, especially within proximal tubular cells. Functionally, ClC-5 mediates the exchange of chloride ions and protons across the membrane of endosomal compartments, enabling proper acidification necessary for receptor-mediated endocytosis and the uptake of low-molecular-weight proteins and albumin. Dysfunction due to CLCN5 mutations causes Dent disease 1, an X-linked renal disorder characterized by proteinuria, renal tubular defects, nephrolithiasis, and progressive kidney failure. The protein belongs to the ClC family of ion channels, forming dimers with a unique structure enabling selective transport functions. As of now, there are no approved drugs that directly target ClC-5; patient management focuses on addressing symptoms and complications of the underlying renal disease.

Other names
Chloride voltage-gated channel 5H(+)/Cl(-) exchange transporter 5CLCN5ClC-5CLCK2DENT1DENTSXLRHhClC-K2hCIC-K2CLC5XRNChloride channel protein 5Chloride transporter ClC-5NPHL1NPHL2chloride channel, voltage-sensitive 5voltage-gated chloride ion channel CLCN5
02

Mechanism of action

Not applicable (no approved drugs directly targeting ClC-5); theoretical interventions could involve modulation of endosomal acidification or chloride ion transport.

03

Biological functions

Ion transport (chloride and proton exchange)Regulation of endosomal acidificationFacilitation of endocytosis and protein uptake in renal proximal tubule cellsMaintenance of intra-endosomal pH and receptor recyclingCellular volume regulation
04

Disease associations

Kidney diseases (Dent disease 1)Hereditary hypophosphatemic ricketsRenal tubular disordersChronic kidney diseaseNephrolithiasis (kidney stones)Bone defects
05

Safety considerations

Loss-of-function mutations lead to impaired proximal tubule reabsorption, risk of kidney failure, tubular proteinuria, bone defects, and nephrolithiasis
06

Interacting drugs

None currently established as direct clinical modulators; disease management is symptomatic and supportive
07

Biomarkers

Genetic variants/mutations in CLCN5 (for diagnosis of Dent disease 1)Low-molecular-weight proteinuria (LMWP)Hypercalciuria

Beyond the preview

Go deeper on Chloride channel protein 5 (ClC-5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chloride channel protein 5 (ClC-5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call